June Hou, MD
Gynecologic Oncology · Bronx, NYNPI 1619192911
Payments from drug & device makers
Across 156 payments — averaging $9866.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$612K
- Eisai Inc.$311K
- Merck$285K
- GSK$101K
- Alkermes, Inc.$66K
- Ascendis Pharma Endocrinology Inc$60K
- plus $104K from 15 others
Across 9 payments — averaging $341.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$3K
What the payments were for
- Consulting fees$22,39096%
- Food & beverage$9494%
- Education$370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 33 | $612,113 |
| Eisai Inc. | 16 | $311,126 |
| Merck | 18 | $284,943 |
| GSK | 18 | $101,315 |
| Alkermes, Inc. | 5 | $65,759 |
| Ascendis Pharma Endocrinology Inc | 15 | $60,156 |
| Seagen Inc. | 8 | $43,888 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32,802 |
| Foundation Medicine, Inc. | 18 | $20,440 |
| Tesaro, Inc. | 7 | $6,169 |
| Incyte Corporation | 1 | $136 |
| AbbVie | 4 | $87 |
| Medtronic | 1 | $71 |
| Kyowa Kirin, Inc. | 2 | $47 |
| Genentech USA, Inc. | 2 | $45 |
| Boehringer Ingelheim | 1 | $29 |
| AstraZeneca | 1 | $26 |
| Solventum Corporation | 1 | $24 |
| Myriad Genetic Laboratories, Inc. | 1 | $23 |
| Dysis Medical, Inc. | 1 | $22 |
| Clovis Oncology, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FOUNDATIONONE CDX$20,440
- FOUNDATIONONE LIQUID$9,475
- FOUNDATIONFOCUS$9,475
- FOUNDATIONONE HEME$9,475
- FOUNDATIONONE$9,475
- ZEJULA$1,950
- OPZELURA$136
How this compares
$1,539,244 in reported general payments places this provider in the 95th percentile of 154 gynecologic oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Bronx
- Gary GoldbergBronx$88K
- Ioannis AlagkiozidisBronx$3K
- Ken LinBronx$3K
- Bhavana PothuriNew York$9.9M
- Jennifer Brown BroderickRochester$9.3M
- Richard MooreRochester$8.9M
- Emese ZsirosBuffalo$5.8M
- Stephanie BlankNew York$3.3M
- Heidi GodoyAlbany$1.8M
- Joyce BarlinAlbany$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.